The pharmaceutical industry – Europe’s most R&D intensive sector – is being damaged by cuts to drugs budgets. This will drive investment in innovation elsewhere, the EU is warned in a letter from Andrew Witty, president of EFPIA
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.